Harvey Herschman

1.1k total citations
21 papers, 933 citations indexed

About

Harvey Herschman is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Harvey Herschman has authored 21 papers receiving a total of 933 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Radiology, Nuclear Medicine and Imaging, 8 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Harvey Herschman's work include Radiopharmaceutical Chemistry and Applications (6 papers), Bone health and treatments (5 papers) and Medical Imaging and Pathology Studies (5 papers). Harvey Herschman is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (6 papers), Bone health and treatments (5 papers) and Medical Imaging and Pathology Studies (5 papers). Harvey Herschman collaborates with scholars based in United States, Sweden and Israel. Harvey Herschman's co-authors include Sandra H. Bigner, Carol J. Wikstrand, Bengt Westermark, M. S. Mahaley, Lawrence F. Eng, Darell D. Bigner, Erkki Ruoslahti, Jan Pontén, Cooper Jf and J. Fenimore Cooper and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Cell Biology and Circulation Research.

In The Last Decade

Harvey Herschman

21 papers receiving 881 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harvey Herschman United States 14 394 204 154 144 123 21 933
P.C. Keng United States 23 781 2.0× 307 1.5× 278 1.8× 220 1.5× 254 2.1× 48 1.4k
Catherine Tang United States 12 602 1.5× 201 1.0× 110 0.7× 73 0.5× 43 0.3× 16 1.1k
Phyllis Wachsberger United States 18 683 1.7× 224 1.1× 112 0.7× 331 2.3× 157 1.3× 41 1.1k
Sanjay Navani Sweden 13 754 1.9× 156 0.8× 123 0.8× 172 1.2× 125 1.0× 18 1.1k
Rob Ruijtenbeek Netherlands 21 854 2.2× 219 1.1× 206 1.3× 90 0.6× 102 0.8× 64 1.2k
Christina M. Restall Australia 12 430 1.1× 304 1.5× 102 0.7× 225 1.6× 170 1.4× 15 969
Janine Stevens United States 8 488 1.2× 195 1.0× 58 0.4× 165 1.1× 50 0.4× 8 829
Rieko Oyama Japan 19 596 1.5× 151 0.7× 103 0.7× 63 0.4× 211 1.7× 53 1.2k
Linda S. Mulcahy United States 11 1.1k 2.7× 492 2.4× 233 1.5× 112 0.8× 41 0.3× 13 1.7k
J.G. Collard Netherlands 24 1.2k 2.9× 297 1.5× 100 0.6× 162 1.1× 73 0.6× 45 1.7k

Countries citing papers authored by Harvey Herschman

Since Specialization
Citations

This map shows the geographic impact of Harvey Herschman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harvey Herschman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harvey Herschman more than expected).

Fields of papers citing papers by Harvey Herschman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harvey Herschman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harvey Herschman. The network helps show where Harvey Herschman may publish in the future.

Co-authorship network of co-authors of Harvey Herschman

This figure shows the co-authorship network connecting the top 25 collaborators of Harvey Herschman. A scholar is included among the top collaborators of Harvey Herschman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harvey Herschman. Harvey Herschman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mongini, Patricia K. A., et al.. (2014). Candidate chromosome 1 disease susceptibility genes for Sjogren's syndrome xerostomia are narrowed by novel NOD.B10 congenic mice. Clinical Immunology. 153(1). 79–90. 5 indexed citations
2.
Quan, Ning, Ying An, Natalya Belevych, et al.. (2014). Prostacyclin mediates endothelial COX-2-dependent neuroprotective effects during excitotoxic brain injury. Journal of Inflammation Research. 7. 57–57. 5 indexed citations
3.
An, Ying, Natalya Belevych, Yu‐Fen Wang, et al.. (2013). Neuronal and nonneuronal COX‐2 expression confers neurotoxic and neuroprotective phenotypes in response to excitotoxin challenge. Journal of Neuroscience Research. 92(4). 486–495. 13 indexed citations
4.
Lu, Yujie, Hidevaldo B. Machado, Qinan Bao, et al.. (2010). In Vivo Mouse Bioluminescence Tomography with Radionuclide-Based Imaging Validation. Molecular Imaging and Biology. 13(1). 53–58. 25 indexed citations
5.
Streicher, John M., Shuxun Ren, Harvey Herschman, & Yibin Wang. (2010). MAPK-Activated Protein Kinase-2 in Cardiac Hypertrophy and Cyclooxygenase-2 Regulation in Heart. Circulation Research. 106(8). 1434–1443. 99 indexed citations
6.
Lu, Yujie, et al.. (2009). Experimental bioluminescence tomography with fully parallel radiative-transfer-based reconstruction framework. Optics Express. 17(19). 16681–16681. 25 indexed citations
7.
Lu, Yujie, Hidevaldo B. Machado, David Stout, et al.. (2009). Spectrally resolved bioluminescence tomography with the third-order simplified spherical harmonics approximation. Physics in Medicine and Biology. 54(21). 6477–6493. 31 indexed citations
8.
Cmarik, Joan L., Harvey Herschman, & Nancy H. Colburn. (1994). Preferential primary‐response gene expression in promotion‐resistant versus promotion‐sensitive JB6 cells. Molecular Carcinogenesis. 11(2). 115–124. 18 indexed citations
9.
Bigner, Darell D., Sandra H. Bigner, Jan Pontén, et al.. (1981). Heterogeneity of Genotypic and Phenotypic Characteristics of Fifteen Permanent Cell Lines Derived from Human Gliomas. Journal of Neuropathology & Experimental Neurology. 40(3). 201–229. 431 indexed citations
10.
Cooper, J. Fenimore, et al.. (1979). Combined Serum and Bone Marrow Radioimmunoassays for Prostatic Acid Phosphatase. The Journal of Urology. 122(4). 498–501. 9 indexed citations
11.
Jf, Cooper, et al.. (1979). Radioimmunoassay for detection of prostatic cancer.. PubMed. 5(2). 24–30. 1 indexed citations
12.
Edgar, David, et al.. (1978). Glucocorticoid induction of tyrosine hydroxylase in a continous cell line of rat pheochromocytoma.. The Journal of Cell Biology. 78(1). R1–R1. 20 indexed citations
13.
Cooper, J. Fenimore, et al.. (1978). A Solid Phase Radioimmunoassay for Prostatic Acid Phosphatase. The Journal of Urology. 119(3). 388–391. 24 indexed citations
14.
Cooper, J. Fenimore, et al.. (1978). The detection of prostatic cancer by radioimmunoassay: A review*. Human Pathology. 9(6). 618–620. 6 indexed citations
15.
Herschman, Harvey, et al.. (1978). Measurement of prostatic acid phosphatase in various cell lines.. PubMed. 55–6. 3 indexed citations
16.
Foti, A, J. Fenimore Cooper, & Harvey Herschman. (1978). Counterimmunoelectrophoresis in determination of prostatic acid phosphatase in human serum.. Clinical Chemistry. 24(1). 140–142. 14 indexed citations
17.
Herschman, Harvey, et al.. (1977). Isozymes of acid phosphatase in normal and cancerous human prostatic tissue.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 37(11). 4120–4. 34 indexed citations
18.
Foti, A, Harvey Herschman, & J. Fenimore Cooper. (1977). Comparison of human prostatic acid phosphatase by measurement of enzymatic activity and by radioimmunoassay.. Clinical Chemistry. 23(1). 95–99. 58 indexed citations
19.
Herschman, Harvey, et al.. (1976). The effect of antibody on human prostatic acid phosphatase. Archives of Biochemistry and Biophysics. 176(1). 154–158. 3 indexed citations
20.
Herschman, Harvey, et al.. (1975). A solid-phase radioimmunoassay for human prostatic acid phosphatase.. PubMed. 35(9). 2446–52. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P.C. Keng Breakdown of academic impact, for papers by Catherine Tang Breakdown of academic impact, for papers by Phyllis Wachsberger Breakdown of academic impact, for papers by Sanjay Navani Breakdown of academic impact, for papers by Rob Ruijtenbeek Breakdown of academic impact, for papers by Christina M. Restall Breakdown of academic impact, for papers by Janine Stevens Breakdown of academic impact, for papers by Rieko Oyama Breakdown of academic impact, for papers by Linda S. Mulcahy Breakdown of academic impact, for papers by J.G. Collard
Rankless by CCL
2026